Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Homology Medicines Inc (FIXX)

Homology Medicines Inc (FIXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 54,338
  • Shares Outstanding, K 58,134
  • Annual Sales, $ 1,160 K
  • Annual Income, $ -112,960 K
  • 60-Month Beta -0.10
  • Price/Sales 46.65
  • Price/Cash Flow N/A
  • Price/Book 0.74
Trade FIXX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.28
  • Most Recent Earnings $-0.24 on 03/12/24
  • Next Earnings Date 05/09/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +199,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8340 +12.07%
on 02/26/24
0.9725 -3.89%
on 03/25/24
+0.0726 (+8.42%)
since 02/23/24
3-Month
0.5611 +66.58%
on 01/03/24
0.9725 -3.89%
on 03/25/24
+0.3637 (+63.70%)
since 12/22/23
52-Week
0.4580 +104.08%
on 11/16/23
1.4800 -36.84%
on 08/01/23
+0.0247 (+2.71%)
since 03/24/23

Most Recent Stories

More News
Homology Medicines: Q3 Earnings Snapshot

Homology Medicines: Q3 Earnings Snapshot

FIXX : 16.8246 (+0.77%)
Homology Medicines: Q2 Earnings Snapshot

Homology Medicines: Q2 Earnings Snapshot

FIXX : 16.8246 (+0.77%)
Homology Medicines: Q1 Earnings Snapshot

Homology Medicines: Q1 Earnings Snapshot

FIXX : 16.8246 (+0.77%)
Homology Medicines: Q4 Earnings Snapshot

Homology Medicines: Q4 Earnings Snapshot

FIXX : 16.8246 (+0.77%)
Homology Medicines: Q3 Earnings Snapshot

Homology Medicines: Q3 Earnings Snapshot

FIXX : 16.8246 (+0.77%)
Homology Medicines Announces Peer-Reviewed Publication on Novel Discovery of AAVHSC with Robust Distribution to the Central Nervous System and Peripheral Organs with Low Affinity for the Liver

AAVHSC16 Biodistribution Properties in Preclinical Models Demonstrated Potential for Systemic Delivery of Genetic Medicines to Brain, Heart and Muscle ...

FIXX : 16.8246 (+0.77%)
Homology Medicines to Present at Upcoming Conferences on its Gene Editing and Gene Therapy Programs for PKU

BEDFORD, Mass., June 29, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today participation and...

FIXX : 16.8246 (+0.77%)
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Homology Medicines, Inc. (FIXX) Shareholders of Class Action Last Few Hours to Actively Participate

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Homology Medicines, Inc. ("Homology" or the "Company") (NASDAQ: FIXX ) and...

FIXX : 16.8246 (+0.77%)
HOMOLOGY DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Homology Medicines, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Homology Medicines, Inc. (“Homology” or the “Company”)...

FIXX : 16.8246 (+0.77%)
Homology Medicines Presents Details of Optimized HMI-103 Nuclease-Free Gene Editing Candidate Featuring Integrated Liver-Specific Promoter to Maximize Long-Term Expression

- Additional Data at ASGCT Annual Meeting Demonstrate Precision of HR-Based Approach with Genome-Wide Integration Assays Confirming On-Target Editing and...

FIXX : 16.8246 (+0.77%)

Business Summary

Homology Medicines Inc. is a genetic medicines company. Its platform offers human hematopoietic stem cell derived adeno-associated virus vectors to treat disease-causing mutations through gene correction, insertion and knockout. Homology Medicines Inc. is based in BEDFORD MA.

See More

Key Turning Points

3rd Resistance Point 1.0440
2nd Resistance Point 1.0082
1st Resistance Point 0.9715
Last Price 16.8246
1st Support Level 0.8990
2nd Support Level 0.8632
3rd Support Level 0.8265

See More

Last Price 16.8246
52-Week High 1.4800
Fibonacci 61.8% 1.0896
Fibonacci 50% 0.9690
Fibonacci 38.2% 0.8484
52-Week Low 0.4580

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar